111 related articles for article (PubMed ID: 10023125)
1. Human studies of recombinant human nerve growth factor and diabetic peripheral neuropathy.
Freeman R
Eur Neurol; 1999; 41 Suppl 1():20-6. PubMed ID: 10023125
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.
Apfel SC; Schwartz S; Adornato BT; Freeman R; Biton V; Rendell M; Vinik A; Giuliani M; Stevens JC; Barbano R; Dyck PJ
JAMA; 2000 Nov; 284(17):2215-21. PubMed ID: 11056593
[TBL] [Abstract][Full Text] [Related]
3. Neurotrophic factors and diabetic peripheral neuropathy.
Apfel SC
Eur Neurol; 1999; 41 Suppl 1():27-34. PubMed ID: 10023126
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophic factors in the therapy of diabetic neuropathy.
Apfel SC
Am J Med; 1999 Aug; 107(2B):34S-42S. PubMed ID: 10484043
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor (NGF) may hold promise in treatment of peripheral neuropathy.
AIDS Patient Care STDS; 1997 Jun; 11(3):197. PubMed ID: 11361801
[No Abstract] [Full Text] [Related]
6. Biological actions of nerve growth factor in the peripheral nervous system.
Rask CA
Eur Neurol; 1999; 41 Suppl 1():14-9. PubMed ID: 10023124
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.
Apfel SC; Kessler JA; Adornato BT; Litchy WJ; Sanders C; Rask CA
Neurology; 1998 Sep; 51(3):695-702. PubMed ID: 9748012
[TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?
Apfel SC
Int Rev Neurobiol; 2002; 50():393-413. PubMed ID: 12198818
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human nerve growth factor and diabetic polyneuropathy.
Zochodne DW; Said G
Neurology; 1998 Sep; 51(3):662-3. PubMed ID: 9748004
[No Abstract] [Full Text] [Related]
10. Development of recombinant human nerve growth factor (rhNGF) as a treatment for peripheral neuropathic disease.
Rogers BC
Neurotoxicology; 1996; 17(3-4):865-70. PubMed ID: 9086510
[TBL] [Abstract][Full Text] [Related]
11. [Nerve growth factor (NGF) in treatment of diabetic polyneuropathy. One hope less?].
Quasthoff S; Hartung HP
Nervenarzt; 2001 Jun; 72(6):456-9. PubMed ID: 11433707
[TBL] [Abstract][Full Text] [Related]
12. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291.
McArthur JC; Yiannoutsos C; Simpson DM; Adornato BT; Singer EJ; Hollander H; Marra C; Rubin M; Cohen BA; Tucker T; Navia BA; Schifitto G; Katzenstein D; Rask C; Zaborski L; Smith ME; Shriver S; Millar L; Clifford DB; Karalnik IJ
Neurology; 2000 Mar; 54(5):1080-8. PubMed ID: 10720278
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophic factors in the therapy of peripheral neuropathy.
Apfel SC; Kessler JA
Baillieres Clin Neurol; 1995 Nov; 4(3):593-606. PubMed ID: 8599726
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophic factors in the treatment of peripheral neuropathy.
Apfel SC; Kessler JA
Ciba Found Symp; 1996; 196():98-108; discussion 108-12. PubMed ID: 8866130
[TBL] [Abstract][Full Text] [Related]
15. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials.
Tesfaye S; Tandan R; Bastyr EJ; Kles KA; Skljarevski V; Price KL;
Diabetes Care; 2007 Oct; 30(10):2626-32. PubMed ID: 17623822
[TBL] [Abstract][Full Text] [Related]
16. Drug shows promise for painful sensory neuropathy.
AIDS Alert; 1998 Dec; 13(12):138-40. PubMed ID: 11366061
[TBL] [Abstract][Full Text] [Related]
17. Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial.
Ferrari MP; Mantelli F; Sacchetti M; Antonangeli MI; Cattani F; D'Anniballe G; Sinigaglia F; Ruffini PA; Lambiase A
BioDrugs; 2014 Jun; 28(3):275-83. PubMed ID: 24327173
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of peripheral neuropathies with neutrotrophic factors: animal models and clinical trials].
Pradat PF
Rev Neurol (Paris); 2003 Feb; 159(2):147-61. PubMed ID: 12660566
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophins and other growth factors in diabetic neuropathy.
Zochodne DW
Semin Neurol; 1996 Jun; 16(2):153-61. PubMed ID: 8987129
[TBL] [Abstract][Full Text] [Related]
20. Ruboxistaurin (Eli Lilly).
Wheeler GD
IDrugs; 2003 Feb; 6(2):159-63. PubMed ID: 12789620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
